Valsartan Tablet, Film Coated
Product Images NDC 50268-749

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Valsartan (NDC 50268-749). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (746 15)

Packaging label for Valsartan Tablets USP 40 mg film-coated tablets, available in a 50-tablet unit dose pack. The label includes dosage strength, manufacturer AvPAK, contact information, storage instructions, and a barcode. The product is for oral use and prescription only.*

FDA Label Image

1 (747 15)

Label for Valsartan Tablets, USP 80 mg film-coated tablets. The label states prescription use only and a package size of 50 tablets in 5 unit dose strips of 10 tablets each. It includes storage instructions, manufacturer contact information, and a barcode. Labeler is AvPAK.*

FDA Label Image

1 (748 15)

Vialsartan Tablets, USP 160 mg film-coated tablets, oral dosage form, packaged as 50 tablets in unit dose (5 x 10) format. The label includes storage instructions, a contact number, and the manufacturer AvPAK located in Pulaski, TN. The label features the AvPAK logo and a QR code.*

FDA Label Image

1 (749 13)

Label for Valsartan Tablets, USP 320 mg, film-coated oral tablets, in a carton containing 30 tablets (6 x 5 unit dose). The label shows NDC 50268-749-13, indicates prescription only, provides storage instructions at 20° to 25°C, and lists AvPAK as the manufacturer located in Pulaski, TN. Contact and website information are also included.*

FDA Label Image

Valsartantabfig1 (Valsartantabfig1)

A forest plot showing comparative data for the drug Valsartan versus Captopril across patient subgroups, including age, gender, ethnicity, geographic region, and beta-blocker use. The horizontal axis ranges from 0.5 (favors Valsartan) to 1.5 (favors Captopril), with a central reference line at 1.0 representing no difference between treatments. Each subgroup is listed with corresponding patient percentages and point estimates with confidence intervals depicted as horizontal lines.*

FDA Label Image

Valsartantabstructure (Valsartantabstructure)

Chemical structure of valsartan, the active ingredient shown in the molecular diagram with detailed bonds and atom groups representing the molecule's composition.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.